AKT1 and breast carcinoma: In a study of breast cancer cells, Jin et al.167 recently demonstrated that PI3K–AKT-mediated inactivation of glycogen synthase kinase-3β (GSK-3β) through phosphorylation induces an abnormal activity of complexes I and III, thus altering electron flow and enhancing ROS production through Mechanism B.